Identification of Lipocalin and Apolipoprotein A1 as Biomarkers of Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record.
Abstract
RATIONALE: Much effort is being made to discover noninvasive biomarkers of chronic airway disease that might enable better management, predict prognosis, and provide new therapeutic targets. OBJECTIVES: To undertake a comprehensive, unbiased proteomic analysis of induced sputum and identify novel noninvasive biomarkers for chronic obstructive pulmonary disease (COPD). METHODS: Induced sputum was obtained from patients with COPD with a spectrum of disease severity and from control subjects. Two-dimensional gel electrophoresis and mass spectrometric identification of differentially expressed proteins were first applied to induced sputum from patients with GOLD stage 2 COPD and healthy smoker control subjects. Initial results thus obtained were validated by a combination of immunoassays (Western blotting and ELISA) applied to a large subject cohort. The biomarkers were localized to bronchial mucosa by immunohistochemistry. MEASUREMENTS AND MAIN RESULTS: Of 1,325 individual protein spots identified, 37 were quantitatively and 3 qualitatively different between the two groups (P < 0.05%). Forty protein spots were subjected to tandem mass spectrometry, which identified 15 separate protein species. Seven of these were further quantified in induced sputum from 97 individuals. Using this sequential approach, two of these potential biomarkers (apolipoprotein A1 and lipocalin-1) were found to be significantly reduced in patients with COPD when compared with healthy smokers. Their levels correlated with FEV(1)/FVC, indicating their relationship to disease severity. CONCLUSIONS: A potential role for apolipoprotein A1 and lipocalin-1 in innate defense has been postulated previously; our discovery of their reduction in COPD indicates a deficient innate defense system in airway disease that could explain increased susceptibility to infectious exacerbations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
Wheelock, C. E., Goss, V. M., Balgoma, D., Nicholas, B., Brandsma, J., Skipp, P. J., Snowden, S., Burg, D., D'Amico, A., Horvath, I., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00078812 · Cited by 272
Self-citationFunctionality of HDL: Antioxidation and Detoxifying Effects
Karlsson, H., Kontush, A., & James, R. W. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-09665-0_5 · Cited by 55
The function of DNA binding protein nucleophosmin in AAV replication
Satkunanathan, S., Thorpe, R., & Zhao, Y. (2017) · Virology · doi:10.1016/j.virol.2017.07.007 · Cited by 24
(2018) · Europe PMC (PubMed Central) · Cited by 17
Metadata
- Authors
- Nicholas, B. L., Skipp, P., Barton, S., Singh, D., Bagmane, D., Mould, R., Angco, G., Ward, J., Guha-Niyogi, B., Wilson, S., Howarth, P., Davies, D. E., Rennard, S., O'Connor, C. D., & Djukanović, R.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-15
- Volume
- 181
- Issue
- 10
- Pages
- 1049-1060
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2099283677
- Cited by
- 75
- References
- 0
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of Lipocalin and Apolipoprotein A1 as Biomarkers of Chronic Obstructive Pulmonary Disease. https://app.cochat.ai/papers/10.1164/rccm.200906-0857oc
- The paper
- Nicholas, B. L., Skipp, P., Barton, S., Singh, D., Bagmane, D., Mould, R., Angco, G., Ward, J., Guha-Niyogi, B., Wilson, S., Howarth, P., Davies, D. E., Rennard, S., O'Connor, C. D., & Djukanović, R. (2010). Identification of Lipocalin and Apolipoprotein A1 as Biomarkers of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200906-0857oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.